Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Lubiprostone in Adult Subjects With Mixed or Unsubtyped Irritable Bowel Syndrome (IBS-M/IBS-U)
Conditions
Interventions
Lubiprostone
Placebo
Locations
16
United States
E Squared Research, Inc.
Huntsville, Alabama, United States
Arkansas Gastroenterology
North Little Rock, Arkansas, United States
GW Research Inc.
Chula Vista, California, United States
Inland Empire Liver Foundation
Rialto, California, United States
Prestige Clinical Research Center
Miami, Florida, United States
Advanced Gastroenterology Associates, LLC
Palm Harbor, Florida, United States
Start Date
February 1, 2015
Primary Completion Date
December 1, 2016
Completion Date
December 1, 2016
Last Updated
December 27, 2019
NCT07481422
NCT05740319
NCT07089420
NCT06866106
NCT05293769
NCT03823742
Lead Sponsor
Sucampo Pharma Americas, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions